Navigate today’s most pressing health industry challenges with a leading global expert by your side.
Meet growing needs for innovative insurance solutions while increasing operational health and improving compliance.
Deliver on the promises of the past and create smart solutions for the future.
Manage complex risks using data-driven insights, advanced approaches, and deep industry experience.
This is a place where your ideas and insights make an impact. Where an independent, entrepreneurial spirit is an advantage. And where diversity of thought and experience makes us who we are.
Data-driven insight. Deep expertise. Transformative innovation. Since 1947, Milliman has delivered intelligent solutions to improve health and financial security.
T.J. is a consulting actuary with the Denver office of Milliman.
T.J.'s primary area of expertise centers around helping insurers with challenges they are facing in the commercial health insurance market, particularly related to healthcare reform. He has experience in product development, pricing, rate filing, and exchange strategy considerations. T.J. has experience working with local, regional, and nationwide insurers, and understands the intricacies of operating in a wide variety of environments as well as the diversity of challenges that carriers of all sizes face. He has also been involved with financial reporting, reserving, and actuarial certifications.
In addition to traditional commercial markets, T.J. has experience working in a wide variety of other actuarial areas. These include preparation of TRICARE bids, including analysis of claim and discount information as well as strategic considerations; analysis of pharmaceutical drug use and impacts; and extensive experience in the behavioral healthcare arena, including capitation, risk analysis, and strategic compliance with the Mental Health Parity and Addiction Equity Act.
T.J. also assists with the development of Milliman's Medical Underwriting Guidelines, with a focus on prescription drugs.
T.J. has coauthored multiple papers related to utilization, adherence, and costs of various prescription drugs. He also coauthored a paper entitled "The Economic Measurement of Medical Errors," which quantifies the cost of medical errors to the United States economy.